U.S. HIV/AIDS Therapies Markets
U.S. HIV/AIDS Therapies Markets
RELEASE DATE
27-Jan-2003
27-Jan-2003
REGION
North America
North America
Research Code: A379-01-00-00-00
SKU: HC00871-NA-MR_04612
$2,450.00
Special Price $1,837.50 save 25 %
In stock
SKU
HC00871-NA-MR_04612
Description
The U.S. HIV/AIDS Therapies Markets report covers the various antiretroviral (ARV) drugs that are currently available in the U.S. namely, NRTIs, PIs and NNRTIs. The report also covers the pipeline drugs from the existing and novel ARV categories, and the HIV vaccines pipeline. Frost & Sullivan Market Engineering Analysis, major market/technology trends, challenges, drivers and restraints and forecasts are covered on a total level and also as at the levels of the various segments. The report cites three prestigious Frost & Sullivan Market Engineering Awards to active industry participants for effective industry approaches.
Table of Contents
Executive Summary
- Executive Summary
HIV/AIDS: Definition and Classification
- Report Scope
- The Human Immunodeficiency Virus
- Acquired Immuno-Deficiency Syndrome(AIDS)
- Etiology and Demography
- Diagnostic Tests
- Overview of HIV/AIDS Therapies
- Highly Active Antiretroviral Therapy(HAART)
Challenges and Strategies
- Overview of Challenges
- Challenge 1: Higher Drug Resistance
- Challenge 2: Inconsistent Patient Adherence
- Challenge 3: Higher Pill Burdens
- Challenge 4: Drug-Induced Dyslipidemia
- Challenge 5: Patients' Lower Tolerability
- Challenge 6: Limited Funds and High Drug Prices
Market Dynamics
- Market Drivers
- Market Restraints
- Pricing Trends
- Demand Analysis
- Revenue Forecasts
- Market Engineering Analysis
Competitive Analysis
- Competitive Structure
- Market Share Analysis
Market Engineering Awards
- Marketing Strategy Leadership Award
- Product Innovation Award
- Business Development Strategy Award
Market Overview
Market Dynamics
Competitive Analysis
Market Overview
Market Dynamics
Competitive Analysis
Market Overview
Market Dynamics
Competitive Analysis
Pipeline ARV Drugs in Novel Categories
HIV/AIDS Vaccines
Related Research
Popular Topics
The U.S. HIV/AIDS Therapies Markets report covers the various antiretroviral (ARV) drugs that are currently available in the U.S. namely, NRTIs, PIs and NNRTIs. The report also covers the pipeline drugs from the existing and novel ARV categories, and the HIV vaccines pipeline. Frost & Sullivan Market Engineering Analysis, major market/technology trends, challenges, drivers and restraints and forecasts are covered on a total level and also as at the levels of the various segments. The report cites three prestigious Frost & Sullivan Market Engineering Awards to active industry participants for effective industry approaches.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | A379-01-00-00-00 |
Is Prebook | No |